FIELD: biotechnology.
SUBSTANCE: invention relates to recombinant nucleic acids encoding antibodies to the Borrelia antigen, and can be used in medicine to prevent or treat Lyme disease. The following is proposed: a nucleic acid molecule that encodes one or more synthetic antibodies to OspA or their functional fragments, which, as part of an expression vector, when administered to a patient, ensures the generation of specific antibodies against the causative agent of Lyme disease.
EFFECT: obtaining DNA antibody constructions for use against Lyme disease.
11 cl, 8 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GLYCAN-DEPENDENT IMMUNOTHERAPY MOLECULES | 2016 |
|
RU2754661C2 |
| COMPOSITIONS AND METHODS OF GENE EDITING | 2019 |
|
RU2804665C2 |
| COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN EXPRESSION | 2017 |
|
RU2795467C2 |
| CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS | 2015 |
|
RU2724999C2 |
| ANTI-C5 ANTIBODIES AND THEIR USE | 2018 |
|
RU2774716C2 |
| THERAPEUTIC AGENTS AND METHODS FOR THE TREATMENT OF TLR2-MEDIATED DISEASES AND DISORDERS | 2019 |
|
RU2791022C2 |
| TREATMENT OF MALIGNANT NEOPLASM USING HUMANIZED CHIMERIC ANTIGEN RECEPTOR AGAINST BCMA | 2015 |
|
RU2751660C2 |
| CHIMERIC ANTIGEN RECEPTORS M971 | 2018 |
|
RU2770411C1 |
| UNNATURAL PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND METHODS OF APPLICATION | 2015 |
|
RU2687150C2 |
| METHODS FOR PRODUCING CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR | 2015 |
|
RU2751362C2 |
